CDC Logo Skip Top Nav
 CDC Home PageSearch the CDCHealth Topics A though Z
Skip
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
 
Skip the Contents menu

Contents

Skip the Resources menu

Resources



U.S. Department of Health and Human Services
 
 

Guide to the Application of Genotyping to Tuberculosis Prevention and Control

Return to Genotyping Main Menu

Tuberculosis Genotyping Case Studies: How TB Programs Have Used Genotyping

Apparent Genotyping Cluster Among Recent Immigrants from the Philippines: IS6110-based RFLP Needed to Discriminate Between Isolates Belonging to the Manila Strain

Previous results from the National Tuberculosis Genotyping and Surveillance Network and other studies showed that spoligotyping alone was not particularly helpful in distinguishing between isolates that belonged to a group generally referred to as the Beijing family of M. tuberculosis isolates. Data from CDC suggest that MIRU analysis, especially when combined with RFLP analysis, will be more discriminatory than spoligotyping alone. At the same time, we are beginning to see new genotyping families that contain isolates that are often not distinguished by spoligotyping plus MIRU analysis. The following case study describes patients with isolates from one such family, which has been named the Manila strain family because of its predominance in patients from Manila.

During 2000--2003, isolates from seven patients were identified as belonging to the same PCR cluster (i.e., each isolate had the same spoligotype and MIRU type). On the basis of the spoligotype and MIRU type, the CDC recognized that these isolates belonged to the Manila family. Analysis of data from the initial case-patient interviews revealed that they were all recent immigrants from the Philippines, but they lived in different regions of Wisconsin. The contact investigations of the cases did not reveal epidemiologic links between any of the patients.

Because no epidemiologic links were identified for these PCR-clustered cases, the TB program requested that the seven isolates be analyzed by RFLP, which revealed seven distinct patterns. Therefore, despite identical spoligotypes and MIRU types, these seven isolates were shown to be genetically distinct by RFLP analysis. The TB program did not undertake a cluster investigation, since the seven isolates were shown not to belong to the same genotyping cluster.

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 

 
Back to Top of Page


If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov


Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov